Evaluating a single intervention product to protect people in both indoor and outdoor contexts from multiple vector-borne diseases.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN61739313

Enrollment

2000

Registered

2025-04-24

Start date

2025-07-01

Completion date

Unknown

Last updated

2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visceral leishmaniasis, malaria and dengue Infections and Infestations

Interventions

BiteBarrier (https://bitebarrier.org/) a spatial emanator for vector control. BiteBarrier contains the insecticide transfluthrin, a pyrethroid. The interventions are to be hung indoors and semi-outdo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Household and willing to participate.

Exclusion criteria

Exclusion criteria: Not of consent age, do not wish to participate.

Design outcomes

Primary

Measure	Time frame
Reduction in visceral leishmaniasis, malaria and dengue vectors measured using CDC-light traps, double net traps and mouth aspiration, form where the BiteBarrier device has been hung inside homes and semi-outdoor spaces in the village, during the two malaria seasons, in 2025 and 2026	—

Secondary

Measure	Time frame
Reduction in visceral leishmaniasis, malaria and dengue as measured using health facility data serving the villages where the BiteBarrier device was distributed – monthly data collected pre, during and one month post malaria season	—

Countries

Ethiopia

Contacts

Public ContactMichael Coleman

michael.coleman@lstmed.ac.uk+44 (0)1517053302

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026